Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography - Trial NCT06409260
Access comprehensive clinical trial information for NCT06409260 through Pure Global AI's free database. This phase not specified trial is sponsored by Matias Vested and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Matias Vested
Rigshospitalet, Denmark
Timeline & Enrollment
N/A
Jun 01, 2024
Jul 01, 2025
Primary Outcome
Time from injection of rocuronium until appearance of the first TOF ratio ≥ 90
Summary
The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime
 TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age
 of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n.
 tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to
 return to TOF 90%) from neuromuscular block than EMG.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06409260
Non-Device Trial